-
-
-
-
-
-
-
-
THOMAS, K. (2016, October 8). Mylan to Pay $465 Million In EpiPen Overpricing Case. New York Times.
-
Snowball, T. R. (2016). The credibility of expert witnesses in patent claim construction: the need to amend Rule 52 under Teva Pharmaceuticals v. Sandoz, Inc. Information & Communications Technology Law
P310-362 -
-
-